US2009012309A1PendingUtilityA1
Chemical compounds
Est. expirySep 27, 2021(expired)· nominal 20-yr term from priority
A61P 9/00A61P 9/10A61P 43/00A61P 37/06A61P 35/00A61P 9/14A61P 3/10A61P 35/04A61P 27/02A61P 29/00A61P 25/28A61P 1/16A61P 17/06C07D 233/90A61P 13/12C07D 405/12A61P 19/02A61P 17/02
49
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Pyrazole derivatives are described herein. The described invention also includes methods of making such pyrazole derivatives as well as methods of using the same in the treatment of diseases.
Claims
exact text as granted — not AI-modified1 . A compound of Formula (I):
wherein:
A is C 3 -C 7 cycloalkyl, aryl or heteroaryl, wherein said C 3 -C 7 cycloalkyl, aryl and heteroaryl is substituted with at least one independently selected R 2 group, and optionally further substituted;
D is hydrogen;
R is independently selected from C 1 -C 6 alkylene, C 2 -C 6 alkenylene, or C 2 -C 6 alkynylene, which alkylene, alkenylene, and alkynylene may optionally be substituted;
R 1 is independently selected from hydrogen, C 1 -C 6 alkyl, aryl, —RR 3 , —C(O)OR 4 , —C(O)NR 5 R 6 , and —C(O)R 4 , which alkyl and aryl may optionally be substituted;
R 2 is independently selected from —NR′″C(O)NR′″R″″, —NR′″—C(═N—CN)—NR′″R″″ or the structure:
R 3 is independently selected from hydrogen, halo, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 3 -C 7 cycloalkyl, C 1 -C 6 alkoxy, C 3 -C 7 cycloalkoxy, C 1 -C 6 haloalkoxy, aryl, aralkyl, aryloxy, heteroaryl, heterocyclyl, —CN, —NHC(O)R, —NHC(S)R 4 , —NR 5 R 6 , —RNR 5 R 6 , —SR 4 , —S(O)R 4 , —S(O) 2 R 4 , —R C (O)OR 4 , —C(O)OR 4 , —C(O)R 4 , —C(O)NR 5 R 6 , —NHS(O) 2 R 4 , —S(O) 2 NR 5 R 6 , or —NHC(═NH)R 4 , which alkyl, haloalkyl, cycloalkyl, alkoxy, cycloalkoxy, haloalkoxy, aryl, aralkyl, aryloxy, heteroaryl and heterocyclyl may optionally be substituted;
R 4 is independently selected from hydrogen, C 1 -C 6 alkyl, aryl, heteroaryl, heterocyclyl, —RR 3 , —NR′″R″″, or —NR′NR′″R″″, which alkyl, aryl, heteroaryl, and heterocyclyl may optionally be substituted;
R 5 is independently selected from hydrogen, C 1 -C 6 alkyl, C 3 -C 7 cycloalkyl, cyanoalkyl, —R′R″, aryl, aralkyl, heteroaryl, —NHC(O)OR′″, —R′NHC(O)OR′″, —R′NHC(O)NR′″R″″, or —R′C(O)OR′″, which alkyl, cycloalkyl, cyanoalkyl, aryl, aralkyl, and heteroaryl may optionally be substituted;
R 6 is independently selected from hydrogen, C 1 -C 6 alkyl, C 3 -C 7 cycloalkyl, cyanoalkyl, —R′R″, aryl, aralkyl, heteroaryl, —C(O)OR′″, or —R′C(O)NR′″R′″, which alkyl, cycloalkyl, cyanoalkyl, aryl, aralkyl, and heteroaryl may optionally be substituted;
R′ is independently selected from optionally substituted C 1 -C 4 alkylene;
R″ is independently selected from optionally substituted heteroalkyl or NR′″R″″;
R′″ is independently selected from hydrogen, C 1 -C 6 alkyl, aryl, aralkyl, heteroaryl, or C 3 -C 7 cycloalkyl, which alkyl, aryl, aralkyl, heteroaryl, and cycloalkyl may optionally be substituted; and
R″″ is independently selected from hydrogen, C 1 -C 6 alkyl, aryl, heteroaryl, or C 3 -C 7 cycloalkyl, which alkyl, aryl, heteroaryl, and cycloalkyl may optionally be substituted;
or a salt, solvate, or physiologically functional derivative thereof.
2 . A compound as claimed in claim 1 , wherein A, said C 3 -C 7 cycloalkyl, aryl or heteroaryl is substituted with one R 2 group and optionally substituted with one or more groups other than R 2 ; or a salt, solvate, or physiologically functional derivative thereof.
3 . A compound as claimed in claim 1 , wherein A is aryl or heteroaryl, substituted with at least one independently selected R 2 group and optionally further substituted; or a salt, solvate, or physiologically functional derivative thereof.
4 . A compound as claimed in claim 1 , wherein R 2 is —NR′″C(O)NR′″R″″.
5 . A compound as claimed in claim 1 , wherein R′″ is hydrogen.
6 . A compound as claimed in claim 1 , wherein R″″ is aryl or heteroaryl, either optionally substituted.
7 . A compound as claimed in claim 1 , wherein R 1 is H or optionally substituted C 1 -C 6 alkyl; or a salt, solvate, or physiologically functional derivative thereof.
8 . A compound as claimed in claim 1 , which is:
-Amino-3-{4-[3-2-(fluoro-5-trifluoromethyl-phenyl)-ureido]-phenyl}-1H-pyrazole-4-carboxylic acid amide;
or a salt, solvate, or physiologically functional derivative thereof.
9 . A compound as claimed in claim 1 , wherein A is phenyl substituted with at least one independently selected R 2 group and optionally further substituted; or a salt, solvate, or physiologically functional derivative thereof.Join the waitlist — get patent alerts
Track US2009012309A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.